30,000,000 Shares of Common Stock ($0.001 Par Value) and Warrants to Purchase up to 60,000,000 Shares of Common Stock Anthera Pharmaceuticals, Inc. Common Stock EQUITY UNDERWRITING AGREEMENTEquity Underwriting Agreement • March 16th, 2017 • Anthera Pharmaceuticals Inc • Pharmaceutical preparations • New York
Anthera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as the representative (the “Representative”) (i) an aggregate of 30,000,000 shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”) and (ii) warrants of the Company to purchase an aggregate of 60,000,000 shares of Common Stock (the “Firm Warrants” and, together with the Firm Shares, the “Firm Securities”). The respective amounts of the Firm Securities to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto. The Company also proposes to sell at the Underwriters’ option (i) an aggregate of up to 4,500,000 additional shares of the Company’s Common Stock (the “Option Shares” and, together with the Firm Shares, the “Shares”) and/or (ii) warrants of the Company to purchase up to an additional 9,000,000 shares of Common St
ContractAt the Market Offering Sales Agreement • March 16th, 2017 • Anthera Pharmaceuticals Inc • Pharmaceutical preparations
